These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 2989707)
21. Immunological and virological investigation in patients with lymphoadenopathy syndrome and in a population at risk for acquired immunodeficiency syndrome (AIDS), with particular focus on the detection of antibodies to human T-lymphotropic retroviruses (HTLV III). Sirianni MC; Rossi P; Scarpati B; Ragona G; Seminara R; Bonomo G; Aiuti F J Clin Immunol; 1985 Jul; 5(4):261-8. PubMed ID: 2995433 [TBL] [Abstract][Full Text] [Related]
22. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592 [TBL] [Abstract][Full Text] [Related]
24. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Sarngadharan MG; Popovic M; Bruch L; Schüpbach J; Gallo RC Science; 1984 May; 224(4648):506-8. PubMed ID: 6324345 [TBL] [Abstract][Full Text] [Related]
25. Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24. Casey JM; Kim Y; Andersen PR; Watson KF; Fox JL; Devare SG J Virol; 1985 Aug; 55(2):417-23. PubMed ID: 2410630 [TBL] [Abstract][Full Text] [Related]
26. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287 [TBL] [Abstract][Full Text] [Related]
27. Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS. Archibald DW; Zon L; Groopman JE; McLane MF; Essex M Blood; 1986 Mar; 67(3):831-4. PubMed ID: 3484980 [TBL] [Abstract][Full Text] [Related]
28. [Prevalence of antibodies against HTLV-III in various regions in Switzerland]. Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208 [TBL] [Abstract][Full Text] [Related]
29. Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area. Rasheed S; Norman GL; Gill PS; Meyer PR; Cheng L; Levine AM Virology; 1986 Apr; 150(1):1-9. PubMed ID: 3006329 [TBL] [Abstract][Full Text] [Related]
30. Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases. Robert-Guroff M; Oleske JM; Connor EM; Epstein LG; Minnefor AB; Gallo RC Pediatr Res; 1987 Jun; 21(6):547-50. PubMed ID: 3474582 [TBL] [Abstract][Full Text] [Related]
31. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia. Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375 [TBL] [Abstract][Full Text] [Related]
32. Serological characterization of HTLV-III infection in AIDS and related disorders. Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434 [TBL] [Abstract][Full Text] [Related]
33. Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire. Biggar RJ; Melbye M; Kestens L; de Feyter M; Saxinger C; Bodner AJ; Paluko L; Blattner WA; Gigase PL Br Med J (Clin Res Ed); 1985 Mar; 290(6471):808-10. PubMed ID: 2983820 [TBL] [Abstract][Full Text] [Related]
34. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115 [TBL] [Abstract][Full Text] [Related]
35. Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex. Goudsmit J; Wolters EC; Bakker M; Smit L; Van der Noordaa J; Hische EA; Tutuarima JA; Van der Helm HJ Br Med J (Clin Res Ed); 1986 May; 292(6530):1231-4. PubMed ID: 3011184 [TBL] [Abstract][Full Text] [Related]
36. LAV/HTLV-III neutralizing antibodies in the sera of patients with AIDS, lymphadenopathy syndrome and asymptomatic seropositive individuals. Faulkner-Valle GP; De Rossi A; Dalla Gassa O; Chieco-Bianchi L Tumori; 1986 Jun; 72(3):219-24. PubMed ID: 3016957 [TBL] [Abstract][Full Text] [Related]
37. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population. Gill PS; Levine AM; Meyer PR; Aguilar SL; Rarick M; Parker JW; Rasheed S Arch Intern Med; 1986 Aug; 146(8):1501-4. PubMed ID: 3015064 [TBL] [Abstract][Full Text] [Related]
38. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682 [TBL] [Abstract][Full Text] [Related]
39. HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. Groopman JE; Salahuddin SZ; Sarngadharan MG; Markham PD; Gonda M; Sliski A; Gallo RC Science; 1984 Oct; 226(4673):447-9. PubMed ID: 6093247 [TBL] [Abstract][Full Text] [Related]